News
Press Releases & Media
Latest updates from Carvolix and our portfolio companies.
Carvolix is born and funded
Press Release
Carvolix is born and funded
- Affluent Medical officially becomes CARVOLIX
- Completion of the acquisitions of CARANX MEDICAL and ARTEDRONE
- 10m€ first tranche of financing completed
February 2026
Le Figaro – Truffle Capital hopes to create a leader in AI applied to cardiology
Press review
Le Figaro – Truffle Capital hopes to create a leader in AI applied to cardiology
February 2, 2026
BFM BUSINESS INTERVIEW – FEBRUARY 2nd, 2026 CARVOLIX LAUNCH – PHILIPPE POULETTY, M.D.
Press review
BFM BUSINESS INTERVIEW
February 2nd, 2026
La Tribune – Medtech: Carvolix, Truffle Capital’s bet to disrupt interventional cardiology
Press review
La Tribune – Medtech: Carvolix, Truffle Capital’s bet to disrupt interventional cardiology
January 19, 2026
Le JDD – Philippe Pouletty, CEO of Truffle Capital “The government must back science and innovation”
Press review
Le JDD – Philippe Pouletty, CEO of Truffle Capital “The government must back science and innovation”
January 18, 2026
BioWorld – Affluent becoming Carvolix after acquisitions
Press review
BioWorld – Affluent becoming Carvolix after acquisitions
January 14, 2026